• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Eli Lilly, ADA and Red Sox star Adam Duvall launch insulin affordability awareness program

June 20, 2023 By Sean Whooley

Eli LillyEli Lilly (NYSE:LLY) and the American Diabetes Association partnered with MLB player Adam Duvall to increase insulin affordability awareness.

Lilly, ADA and Duvall agreed to launch a nationwide effort to highlight affordable insulin for all living with diabetes. This effort comes on the heels of Lilly’s announcement in March that it planned to significantly cut insulin prices. That announcement featured plans to execute price reductions of 70% for its most commonly prescribed insulins.

Indianapolis-based Lilly also expanded its Insulin Value Program, capping patient out-of-pocket costs at $35 or less per month. The company said it took these actions to “help Americans” in a “complex healthcare system” that can keep them from receiving affordable insulin.

The latest effort, called the “Tap the Cap” campaign, aims to underscore how easy it is to access Lilly’s $35 insulin. Lilly also plans to give back to the diabetes community through contributions to local ADA summer camps.

“Earlier this year, Lilly further delivered on our commitment to provide affordable insulin for people with diabetes by announcing price reductions of 70% for our most commonly prescribed insulins and an expansion of our Insulin Value Program to automatically cap patient out-of-pocket costs at $35 or less per month. And we promised we wouldn’t stop there,” said Mike Mason, president, Lilly Diabetes. “Today, we’re staying true to our word and are excited to launch a new campaign to help ensure Lilly insulin users are aware of how they can tap our $35 insulin cap.”

More about the Eli Lilly “Tap the Cap” campaign

Lilly and the ADA said they share the mission of advocating for insulin affordability. They aim to ensure all with diabetes have access to the medicines and treatments they need.

“With 8.4 million Americans relying on insulin to manage their diabetes, it’s critically important they can afford it. The ADA has long led the fight for insulin affordability, and we’re proud to team up with Lilly to inform people about how they can access affordable insulin,” said Charles “Chuck” Henderson, CEO of the ADA.

Lilly and the ADA also received support from Boston Red Soc outfielder Adam Duvall. The professional baseball player received a type 1 diabetes diagnosis in 2012. He became an advocate for the importance of diabetes education and navigating life with the disease. Duvall plays baseball with his insulin pump stored in his back pocket.

“I know firsthand the physical and emotional burden that living with diabetes can have,” said Duvall. “The last thing a person should have to worry about is how to get affordable insulin, and that’s why I’m glad to be spreading the word with Lilly to make sure people know how easy it is to Tap the Cap.”

Lilly aims to spread awareness on social media through its #TaptheCap filter and hashtag #TaptheCap. For every post with the hashtag, the company plans to make a contribution to the ADA’s U.S.-based summer camps.

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured Tagged With: American Diabetes Association, Eli Lilly, Eli Lilly & Co.

IN CASE YOU MISSED IT

  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes
  • Medtronic Diabetes names CFO with consumer experience ahead of separation
  • Diabeloop launches insulin delivery algorithm in Germany
  • GlucoModicum has positive data for needle-free CGM
  • Lifecare takes next steps in CGM implant development

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS